Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Melflufen |
Trade Name | |
Synonyms | mel-flufen|Melphalan Flufenamide |
Drug Descriptions |
Melflufen (Melphalan Flufenamide) is a lipophilic alkylating agent that induces DNA damage, potentially resulting in increased tumor cell death (PMID: 27098276, PMID: 29029544). |
DrugClasses | Chemotherapy - Alkylating 18 |
CAS Registry Number | 380449-51-4 |
NCIT ID | C107680 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bortezomib + Dexamethasone + Melflufen | Bortezomib Dexamethasone Melflufen | 0 | 1 |
Daratumumab + Dexamethasone + Melflufen | Daratumumab Dexamethasone Melflufen | 0 | 2 |
Dexamethasone + Melflufen | Dexamethasone Melflufen | 0 | 3 |
Melflufen | Melflufen | 0 | 0 |